These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27993653)

  • 21. In vitro Drug Metabolism Investigation of 7-Ethoxycoumarin in Human, Monkey, Dog and Rat Hepatocytes by High Resolution LC-MS/MS.
    Feng WY; Wen J; Stauber K
    Drug Metab Lett; 2018; 12(1):33-53. PubMed ID: 29669508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of BVT.2938 metabolites by LC/MS and LC/MS/MS after in vitro incubations with liver microsomes and hepatocytes.
    Edlund PO; Baranczewski P
    J Pharm Biomed Anal; 2004 Mar; 34(5):1079-90. PubMed ID: 15019042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes.
    Kim H; Yoon YJ; Kim H; Cha EY; Lee HS; Kim JH; Yi KY; Lee S; Cheon HG; Yoo SE; Lee SS; Shin JG; Liu KH
    Arch Pharm Res; 2005 Nov; 28(11):1287-92. PubMed ID: 16350857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative
    Solà J; Menargues À; Homedes J; Salichs M; Serafini MT; Encina G
    Drug Metab Lett; 2021; 14(3):206-218. PubMed ID: 34886785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide in rats: evidence for bioactivation through alcohol-O-glucuronidation and O-sulfation.
    Cui D; Rankin GO; Harvison PJ
    Chem Res Toxicol; 2005 Jun; 18(6):991-1003. PubMed ID: 15962934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.
    Hewitt NJ; Bühring KU; Dasenbrock J; Haunschild J; Ladstetter B; Utesch D
    Drug Metab Dispos; 2001 Jul; 29(7):1042-50. PubMed ID: 11408372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes.
    Uchiyama M; Koda H; Fischer T; Mueller J; Yamamura N; Oguchi M; Iwabuchi H; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 Jul; 39(7):1311-9. PubMed ID: 21511943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the metabolites of TUG-891 in rat, dog, and human hepatocytes using ultra-high-performance liquid chromatography tandem mass spectrometry and nuclear magnetic resonance spectroscopy.
    Shi Q; Liu Y; Liu C; Wang J
    Rapid Commun Mass Spectrom; 2020 Jun; 34(11):e8766. PubMed ID: 32108961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective degradation and toxic effects of benalaxyl on blood and liver of the Chinese lizard Eremias argus.
    Wang Y; Guo B; Gao Y; Xu P; Zhang Y; Li J; Wang H
    Pestic Biochem Physiol; 2014 Jan; 108():34-41. PubMed ID: 24485313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformation of the anti-angiogenic compound SU5416.
    Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes.
    Lavrijsen K; van Houdt J; van Dyck D; Hendrickx J; Bockx M; Hurkmans R; Meuldermans W; Le Jeune L; Lauwers W; Heykants J
    Xenobiotica; 1992 Jul; 22(7):815-36. PubMed ID: 1455902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species differences in the formation of vabicaserin carbamoyl glucuronide.
    Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
    Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
    Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro metabolism of 14C-ciclesonide in hepatocytes from the mouse, rat, rabbit, dog, and human.
    Gu Z; Zhao XG; Nave R; Liu DD; Feng H; Wu J; Howell SR; Guo Z
    Am J Ther; 2007; 14(3):280-90. PubMed ID: 17515705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo metabolism of desogestrel in several species.
    Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM
    Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the site of glucuronidation in an N-(3,5-dichlorophenyl)succinimide metabolite by electrospray ionization tandem mass spectrometry following derivatization to picolinyl esters.
    Cui D; Harvison PJ
    Rapid Commun Mass Spectrom; 2000; 14(21):1985-90. PubMed ID: 11085408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry.
    Lafaille F; Solassol I; Enjalbal C; Bertrand B; Doulain PE; Vappiani J; Bonnet PA; Deleuze-Masquéfa C; Bressolle FM
    J Pharm Biomed Anal; 2014 Jan; 88():429-40. PubMed ID: 24176748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes.
    Li L; Chen X; Li D; Zhong D
    Drug Metab Dispos; 2011 Mar; 39(3):472-83. PubMed ID: 21139039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.